Urticaria and Angioedema
| Author | : | |
| Rating | : | 4.61 (640 Votes) |
| Asin | : | 0824753151 |
| Format Type | : | paperback |
| Number of Pages | : | 400 Pages |
| Publish Date | : | 2013-07-08 |
| Language | : | English |
DESCRIPTION:
Exploring current treatment options for skin conditions affecting more than 20% of the population, this reference examines every type of urticaria and angioedema, reviews the mechanisms common to all types of these disorders, and discusses the uses and limitations of existing and emerging treatment regimens for urticaria and angioedema, including alternative therapeutic approaches.
[] Book Review This book is a must for health care providers caring for patients with urticaria and angioedema. The editors, Greaves and Kaplan, achieve their objective of providing clinicians with "a clear guide to the diagnosis and management of this often perplexing group of diseases." In addition, immunologists, cell biologists, and pharmacologists will find the chapters that attempt to unravel the complex biology underlying these diseases quite stimulating. The list of contributors includes several well-known experts in the field including Howard Maibach, Larry Millikan, and Nicholas Soter.A rel
. Readers who are interested in the basic mechanisms of these conditions will find chapters dealing with the biology of mast cells and basophils, the IgE-dependent allergic response, and the complement and bradykinin mediator systems. As in any textbook with multiple authors, there is some redundancy. From The New England Journal of Medicine It would be unusual to find more than a single chapter devoted to urticaria and angioedema in most medical textbooks, including those devoted to allergies and to dermatology. Although this is a drawback, I find it a small one that is counteracted by the differences among authors regarding emphasis and perspective. All rights reserved. The book is a useful blend of bench and clinical science. I commend the editors and authors for presenting "off label" treatments -- including H(sub 2)-receptor blockers, leu